The Application segment delineates the end‑use environments that drive demand for Life Science Plastic Bottles. Pharmaceuticals dominate the landscape, accounting for roughly 45 % of total volume, as these containers are essential for sterile drug formulation, oral liquids, and injectable solutions. Diagnostics represent about 30 % of the market, supplying reagents, sample collection tubes, and point‑of‑care kits where precise dosing and barrier properties are critical. Research & Development consumes near 15 % of the market, providing flexible, low‑volume bottles for laboratory assays, cell culture media, and analytical standards. The remaining 10 % is attributed to Biotechnology applications, including bioprocessing and biologics manufacturing, where high‑purity, low‑extractable polymers are required. Each application contributes uniquely to the overall market size by imposing distinct regulatory, material, and performance criteria, thereby shaping product design, pricing, and supply‑chain dynamics within the Life Science Plastic Bottles segmentation framework.